Literature DB >> 23352670

Intestinal dendritic cells: their role in intestinal inflammation, manipulation by the gut microbiota and differences between mice and men.

Elizabeth R Mann1, Jonathan D Landy, David Bernardo, Simon T C Peake, Ailsa L Hart, Hafid Omar Al-Hassi, Stella C Knight.   

Abstract

The intestinal immune system maintains a delicate balance between immunogenicity against invading pathogens and tolerance of the commensal microbiota and food antigens. Dendritic cells (DC) generate primary T-cell responses, and determine whether these responses are immunogenic or tolerogenic. The regulatory role of DC is of particular importance in the gut due to the high antigenic load. Intestinal DC act as sentinels, sampling potentially pathogenic antigens but also harmless antigens including the commensal microbiota. Following antigen acquisition, intestinal DC migrate to secondary lymphoid organs to activate naive T-cells. DC also imprint specific homing properties on T-cells that they stimulate; gut DC specifically induce gut-homing properties on T-cells upon activation, enabling T-cell migration back to intestinal sites. Data regarding properties on gut DC in humans is scarce, although evidence now supports the role of DC as important players in intestinal immunity in humans. Here, we review the role of intestinal DC in shaping mucosal immune responses and directing tissue-specific T-cell responses, with a special focus on the importance of distinguishing DC subsets from macrophages at intestinal sites. We compare and contrast human DC with their murine counterparts, and discuss the ability of the gut microbiota to shape intestinal DC function, and how this may be dysregulated in inflammatory bowel disease (IBD). Lastly, we describe recent advances in the study of probiotics on intestinal DC function, including the use of soluble secreted bacterial products.
Copyright © 2013. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2013        PMID: 23352670     DOI: 10.1016/j.imlet.2013.01.007

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  41 in total

Review 1.  Strain-Related Differences in the Immune Response: Relevance to Human Stroke.

Authors:  Kyra J Becker
Journal:  Transl Stroke Res       Date:  2016-02-10       Impact factor: 6.829

Review 2.  Use of Humanized Mice to Study the Pathogenesis of Autoimmune and Inflammatory Diseases.

Authors:  Iurii Koboziev; Yava Jones-Hall; John F Valentine; Cynthia Reinoso Webb; Kathryn L Furr; Matthew B Grisham
Journal:  Inflamm Bowel Dis       Date:  2015-07       Impact factor: 5.325

Review 3.  Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?

Authors:  Georgina L Hold; Megan Smith; Charlie Grange; Euan Robert Watt; Emad M El-Omar; Indrani Mukhopadhya
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

Review 4.  Intestinal barrier: A gentlemen's agreement between microbiota and immunity.

Authors:  Andrea Moro Caricilli; Angela Castoldi; Niels Olsen Saraiva Câmara
Journal:  World J Gastrointest Pathophysiol       Date:  2014-02-15

Review 5.  Gut microbiota impact on stroke outcome: Fad or fact?

Authors:  Katarzyna Winek; Andreas Meisel; Ulrich Dirnagl
Journal:  J Cereb Blood Flow Metab       Date:  2016-03-04       Impact factor: 6.200

Review 6.  T-cell selection and intestinal homeostasis.

Authors:  Teresa L Ai; Benjamin D Solomon; Chyi-Song Hsieh
Journal:  Immunol Rev       Date:  2014-05       Impact factor: 12.988

7.  Microbiota Metabolite Short-Chain Fatty Acids Facilitate Mucosal Adjuvant Activity of Cholera Toxin through GPR43.

Authors:  Wenjing Yang; Yi Xiao; Xiangsheng Huang; Feidi Chen; Mingming Sun; Anthony J Bilotta; Leiqi Xu; Yao Lu; Suxia Yao; Qihong Zhao; Zhanju Liu; Yingzi Cong
Journal:  J Immunol       Date:  2019-05-10       Impact factor: 5.422

8.  Protein kinase p38α signaling in dendritic cells regulates colon inflammation and tumorigenesis.

Authors:  Tingting Zheng; Baohua Zhang; Ce Chen; Jingyu Ma; Deyun Meng; Jian Huang; Ran Hu; Xinguang Liu; Kinya Otsu; Andrew C Liu; Huabin Li; Zhinan Yin; Gonghua Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-12       Impact factor: 11.205

Review 9.  A shift in paradigm towards human biology-based systems for cholestatic-liver diseases.

Authors:  Fozia Noor
Journal:  J Physiol       Date:  2015-11-04       Impact factor: 5.182

10.  Protective effect of Lactobacillus reuteri DSM 17938 against experimental necrotizing enterocolitis is mediated by Toll-like receptor 2.

Authors:  Thomas K Hoang; Baokun He; Ting Wang; Dat Q Tran; J Marc Rhoads; Yuying Liu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-04-12       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.